Luisa Vinciguerra. Ictus recidivanti

Similar documents
NeuroPI Case Study: Anticoagulant Therapy

Disclosures. An Update on TIA and Minor Stroke. The Agenda PROGNOSIS PATHOPHYSIOLOGY GUIDELINES AND PROVEN MANAGEMENT STRATEGIES AGGRESSIVE TREATMENT

A common clinical dilemma. Ischaemic stroke or TIA with atrial fibrillation MRI scan with blood-sensitive imaging shows cerebral microbleeds

Antithrombotic therapy in patients with transient ischemic attack / stroke (acute phase <48h)

Restart or stop antithrombotics after intracerebral haemorrhage (ICH)?

Controversies in Risk Stratification

Secondary Preven-on of Thromboembolic Stroke: Clinical Data and Recommenda-ons from the ESC Atrial Fibrilla-on Guideline Update 2012

Evaluate Risk of Stroke & Bleeding in AF Patients

Risk Stratification for Stroke Prevention in Patients with Atrial Fibrillation: The emerging role of biomarkers

Atrial Fibrillation. 2 nd Annual National Hospitalist Conference San Antonio, TX September 7, 2018

Identifying Patients for Anticoagulation: While Many Patients Remain Untreated, Who Should NOT be Anticoagulated?

Advances in the treatment of posterior cerebral circulation symptomatic disease

Supplementary appendix

Results from RE-LY and RELY-ABLE

Peri-operative Troponin Measurements - Pathophysiology and Prognosis

03/30/2016 DISCLOSURES TO OPERATE OR NOT THAT IS THE QUESTION CAROTID INTERVENTION IS INDICATED FOR ASYMPTOMATIC CAROTID OCCLUSIVE DISEASE

Stratificazione del rischio, corretto bilancio tra ischemia e bleeding: il beneficio clinico netto

ECG monitoring after ischemic stroke of TIA of unknown source with an insertable monitor? YES

It is the nature of a stroke to partly take away the use of a man s limbs and to throw him onto the parish if he had no children to look to

Stroke secondary prevention. Gill Cluckie Stroke Nurse Consultant St. George s Hospital

Troponin I elevation increases the risk of death and stroke in patients with atrial fibrillation a RE-LY substudy. Ziad Hijazi, MD

Indications of Anticoagulants; Which Agent to Use for Your Patient? Marc Carrier MD MSc FRCPC Thrombosis Program Ottawa Hospital Research Institute

Secondary Stroke Prevention

Risk Factors for Ischemic Stroke: Electrocardiographic Findings

STROKE UPDATE ANTHEA PARRY MAY 2010

Stroke & the Emergency Department. Dr. Barry Moynihan, March 2 nd, 2012

Alma Mater Studiorum Università di Bologna

Apixaban for stroke prevention in atrial fibrillation. August 2010

Transient Atrial Fibrillation and Risk of Stroke after Acute Myocardial Infarction

Show Me the Outcomes!

Atrial fibrillation and anticoagulation JIR-PING BOEY, DEPARTMENT OF HAEMATOLOGY, FLINDERS MEDICAL CENTRE FEBRUARY 2016

Dr Julia Hopyan Stroke Neurologist Sunnybrook Health Sciences Centre

Thromboembolism During Sinus Rhythm in Patients with a History of Atrial Fibrillation

Prevenzione secondaria dell ischemia cerebrale di origine arteriosa. Marco Cattaneo. Ospedale San Paolo Università degli Studi di Milano

Rehospitalization for Stroke among Elderly TIA Patients

Redgrave JN, Coutts SB, Schulz UG et al. Systematic review of associations between the presence of acute ischemic lesions on

How to Choose Between Carotid Stenting and Carotid Endarterectomy for Stroke Prevention

ORIGINAL CONTRIBUTION. Early Stroke Risk After Transient Ischemic Attack Among Individuals With Symptomatic Intracranial Artery Stenosis

Starting or Resuming Anticoagulation or Antiplatelet Therapy after ICH: A Neurology Perspective

Bath, Philip M.W. and England, Timothy J. (2009) Thighlength compression stockings and DVT after stroke. Lancet. ISSN (In Press)

TROPONINS HAVE THEY CHANGED YOUR

MORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS. 73 year old NS right-handed male applicant for $1 Million Life Insurance

Giuseppe Micieli Dipartimento di Neurologia d Urgenza IRCCS Fondazione Istituto Neurologico Nazionale C Mondino, Pavia

Why Treat Patent Forman Ovale

controversies in anticoagulation: optimizing outcome for atrial fibrillation

Digoxin And Mortality in Patients With Atrial Fibrillation With and Without Heart Failure: Does Serum Digoxin Concentration Matter?

Updates in Atrial Fibrillation

La terapia antiaggregante nel paziente con stroke

Missed opportunities for secondary prevention of cerebrovascular disease in elderly British men from 1999 to 2005: a population-based study

5/2/2016. Outpatient Stroke Management Sheila Smith MD May 5, 2016

CADTH Therapeutic Review

Anticoagulants and Head Injuries. Asaad Shujaa,MD,FRCPC,FAAEM Assistant Professor,weill Corneal Medicne Senior Consultant,HMC Qatar

Stroke Prevention in AF: How will it change in the next 5 years? Jeff Healey MD, MSc, FHRS Population Health Research Institute McMaster University

Investigators meeting. Thursday 7 June 2012

MORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS. 73 year old NS right-handed male applicant for $1 Million life insurance

Approximately 30% of strokes in population-based studies

MODULE 1: Stroke Prevention in Atrial Fibrillation Benjamin Bell, MD, FRCPC

INTRACEREBRAL HAEMORRHAGE:

Carotid Artery Stenosis

How Long Patietns Will Be on Dual Antiplatelet Therapy?

Consensus document: Screening and Prevention of Atrial Fibrillation

2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Outcome

Comorbidity or medical history Existing diagnoses between 1 January 2007 and 31 December 2011 AF management care AF symptoms Tachycardia

BNP as a Predictor of Cardiovascular Disease and All Cause Mortality. Dr. Thierry Le Jemtel

Advances in Prevention and Treatment of Stroke: What Every Primary Care Physician Needs to Know. Case 1 4/5/11. What treatment should you initiate?

Biomarkers and Arrhythmias/Devices Ulrika Birgersdotter-Green, M.D.

Defining Sub-Clinical Atrial Fibrillation and its management

V. Roldán, F. Marín, B. Muiña, E. Jover, C. Muñoz-Esparza, M. Valdés, V. Vicente, GYH. Lip

'VENICE'ARRYTHMIAS'2015'' Venice,'17 th 'October'2015''

Antithrombotics in Stroke management

Michael Horowitz, MD Pittsburgh, PA

Mario Plebani University-Hospital of Padova, Italy

Does ABCD 2 Score Below 4 Allow More Time to Evaluate Patients With a Transient Ischemic Attack?

Atrial Fibrillation & Acute Stroke

The Challenge. Warfarin or Novel Oral Anti-Coagulants in the PCI patient? Anticoagulation/Stroke

Acute stroke. Ischaemic stroke. Characteristics. Temporal classification. Clinical features. Interpretation of Emergency Head CT

The secondary prevention of ischemic stroke is aided by the use of antiplatelet therapy,

Stroke in the ED. Dr. William Whiteley. Scottish Senior Clinical Fellow University of Edinburgh Consultant Neurologist NHS Lothian

The Effect of Statin Therapy on Risk of Intracranial Hemorrhage

Early Hospitalization of Patients with TIA: A Prospective, Population-based Study

Acute coronary syndromes A European viewpoint. Felicita Andreotti, MD PhD FESC Catholic University Hospital Cardiovascular Diseases - Rome, IT

Carotid Artery Stenting Today: A Few Updating Remarks

Thrombolysis-WAKE UP Intra-arterial interventions DEFUSE 3 Haemorrhagic Stroke - TICH 2 Secondary Prevention CROMIS 2 Secondary Prevention NAVIGATE

Aspirin to Prevent Heart Attack and Stroke: What s the Right Dose?

Stroke Update. Claire J. Creutzfeldt, MD January 12, 2018

Draft Agreed by Cardiovascular Working Party 25 Jan Adoption by CHMP for release for consultation 17 Feb 2011

New options in Stroke Prevention in AF Paul Dorian University of Toronto St Michael s Hospital

Management of Patients with Atrial Fibrillation Undergoing Coronary Artery Stenting 경북대의전원내과조용근

To provide information on the use of acetyl salicylic acid in the treatment and prevention of vascular events.

Controversies in Risk Stratification

NQF ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE. Measure Information Form Collected For: The Joint Commission Only CMS Voluntary Only

TIA: Updates and Management 2008

NOAs for stroke prevention in Atrial Fibrillation: potential advantages in the elderly patients. Giancarlo Agnelli

Prof. Jindřich Špinar, MD

Atrial Fibrillation and Heart Failure: A Cause or a Consequence

Role of Clopidogrel in Acute Coronary Syndromes. Hossam Kandil,, MD. Professor of Cardiology Cairo University

Stroke and transient ischaemic attack -

Carotid Artery Disease How the Data Will Influence Management The Symptomatic vs. the Asymptomatic Patient

Biomarkers and Arrhythmias/Devices Ulrika Birgersdotter-Green, MD, FHRS

Transcription:

Luisa Vinciguerra Ictus recidivanti

Recurrent Strokes DEFINITION Population-based studies exclude strokes: - within 28 or 21 days of the incident event - events in the same vascular territory as the original event In contrast, other studies included: - events occurring 24 hours after the incident event - a new focal neurological deficit occurring at any time after the index stroke Sarti et al. Stroke. 2003;34:1833 1841. Coull et al. Stroke. 2004;35:1925-1929. Kolominsky-Rabas et al. Stroke. 1998;29:2501 2506. Lovett et al. Neurology. 2004;62:569 574.

Recurrent Strokes Coull et al. Stroke. 2004;35:1925-1929.

Recurrent Strokes 30% of strokes in population-based studies are recurrent events Recurrent strokes are more likely to be disabling or fatal than first strokes Coull et al. Stroke. 2004;35:1925-1929.

The equivalent risk after a first-ever ischemic stroke is usually reported as 2% to 6% Approximately 2% 5% of recurrent stroke occurred early within 24 48 hours after the index event Wangqin R, et al. Stroke and Vascular Neurology 2017;0:e000088. Coull et al. Stroke. 2004;35:1925-1929. Lovett et al. Stroke. 2003;34:e138-e140. Sacco et al. Stroke, 1982:13;3.

Risk of recurrent stroke (%) After ischaemic stroke and TIA: without treatment The risk of stroke in the 3 months after a transient ischemic attack (TIA) is as much as 15% to 20% in population-based studies Coull et al. BMJ 2004; 328: 326. Hankey. Lancet. 2017;389:641-654.

The cumulative risk of stroke recurrence after first-ever stroke Mohan et al. Stroke 2011; 42: 1489 94. Coull et al. Stroke. 2004;35:1925-1929. Lovett et al. Stroke. 2003;34:e138-e140. Sacco et al. Stroke, 1982:13;3.

After haemorrhagic stroke: The annual risks of recurrent intracerebral haemorrhage and ischaemic stroke are similar, from 1 3% to 7 4% The risk of recurrent intracerebral haemorrhage is higher after - lobar intracerebral haemorrhage - inadequate blood pressure control Poon et al. J Neurol Neurosurg Psychiatry 2014; 85: 660 67. Biffi et al. JAMA 2015; 314: 904 12.

Kiyohara et al. Stroke 2014; 45: 418 25. Arsava et al. JAMA Neurol 2016;73: 396 401. Hankey. Lancet. 2017;389:641-654.

The risk is higher with: - Symptomatic atherosclerotic disease - Vascular risk factors - Active source of thrombosis - Discontinued antiplatelet and antihypertensive therapy For patients with atrial fibrillation the risk of stroke increases with: - higher CHADS2 - CHA2DS2-VASc - ABC (Age, Biomarkers [NT-proBNP and ctn-hs], and Clinical history [prior stroke or TIA]) stroke scores Hijazi et al. Eur Heart J 2016;37: 1582 90.

CHADS2 and CHA2DS2-VASc Gage et al. Circulation. 2004;110(16):2287-92. Gage et al. JAMA. 2001;285(22):2864-70. Lip et al. Am J Med 2010;123(6);484-488.

ABC-stroke risk score Nomogram for the new biomarker-based risk score: For each predictor, read the points assigned on the 0 10 scale at the top and then sum these points. Find the number on the Total Points scale and then read the corresponding predictions of 1- and 3-year risk of stroke or systemic embolism below it. Continuous variables are represented from the 1st to the 99th percentiles. The prediction model is preferably used as a web-based calculator or app. Hijazi et al. Eur Heart J 2016;37: 1582 90.

ABC-stroke risk score Example 1: A 75-year old woman with atrial fibrillation, hypertension, no prior stroke, troponin-i levels of 5 ng/l, and NT-proBNP levels of 400 ng/l. By using the ABC-stroke score nomogram receives 2p for age, 1.75p for troponin levels, and 5p for NT-proBNP levels. A total of 8.75 p would equal a predicted 1-year risk of stroke or systemic embolism below 1.0% and a 3-year risk of 2.0%. Hijazi et al. Eur Heart J 2016;37: 1582 90.

ABC-stroke risk score Example 2: A 64-year old man with atrial fibrillation, heart failure, troponin levels of 75 ng/l, and NTproBNP levels of 3000 ng/l. By using the ABC-stroke score nomogram receives 1.25p for age, 4.75p for troponin, and 8.75p for NT-proBNP levels. A total of 14.75p would equal a predicted 1-year and 3-year risk of stroke or systemic embolism of 2.0% and 4.8%, respectively. Hijazi et al. Eur Heart J 2016;37: 1582 90.

PREVENTING RECURRENT ISCHAEMIC STROKE OF ARTERIAL ORIGIN Urgent initiation of effective secondary prevention after TIA and minor ischaemic stroke can reduce the risk of early recurrent stroke by 80% Rothwell et al. Lancet 2007;370: 1432 42. Hankey. Lancet. 2017;389:641-654.

PREVENTING RECURRENT ISCHAEMIC STROKE OF ARTERIAL ORIGIN Urgent initiation of effective secondary prevention after TIA and minor ischaemic stroke can reduce the risk of early recurrent stroke by 80% Rothwell et al. Lancet 2016; 388: 365 75. Sandercock et al. Cochrane Database Syst Rev 2014;,3: CD000029. Hankey. Lancet. 2017;389:641-654.

PREVENTING RECURRENT ISCHAEMIC STROKE OF ARTERIAL ORIGIN Baigent et al. Lancet 2009;373: 1849 60. Liu et al. Hypertens Res 2009; 32: 1032 40. Amarenco et al. Lancet Neurol 2009; 8: 453 63. Hankey. Lancet. 2017;389:641-654.

PREVENTING RECURRENT ISCHAEMIC STROKE OF CARDIAC ORIGIN Saxena et al. Cochrane Database Syst Rev 2004;2: CD000185. Ruff et al. Lancet 2014; 383: 955 62. Holmes et al. J Am Coll Cardiol 2015;65: 2614 23. Hankey. Lancet. 2017;389:641-654.

CONCLUSION Despite these advances, the global burden of stroke remains substantial and is increasing as populations age A standard definition of recurrent stroke is also required so that different studies can be compared or meta-analyzed appropriately, time trends in risk can be determined accurately, and absolute risk reductions with treatment can be properly compared across trials Further research therefore is needed to investigate the effect of acute stroke management and secondary prevention measures on the risk of stroke recurrence from the first weeks to beyond years after first stroke

Grazie per l Attenzione